Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupen Hargreaves

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Haematology|November 4, 2022
Challenges of diagnosing and managing pre-fibrotic myelofibrosis: A case-based and practical approachAlexandros Rampotas, Rupen Hargreaves, Donal P McLornan
Current Research in Translational Medicine|February 26, 2022
Diagnostic and management strategies for Myeloproliferative Neoplasm-Unclassifiable (MPN-U): An international survey of contemporary practiceRupen Hargreaves, Claire N Harrison, Donal P McLornan
Cell Reports. Medicine|August 9, 2025
Inflammation reprogramming and immunomodulation: Next-generation treatments for atherosclerosisRobin P Choudhury, Rupen Hargreaves, Jason Chai, et al.
British Journal of Haematology|February 22, 2022
How I manage myeloproliferative neoplasm-unclassifiable: Practical approaches for 2022 and beyondDonal P McLornan, Rupen Hargreaves, Juan Carlos Hernández-Boluda, et al.
NPJ Cardiovascular Health|May 20, 2026
Clonal haematopoiesis and cardiovascular disease, defining risk, filling gaps, and framing the futureAlec P Morley, Paul Carter, Rupen Hargreaves, et al.
Cell Stem Cell|February 24, 2026
comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disordersYuqi Shen, Camelia Benlabiod, Edmund Watson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Haematology|November 4, 2022
Challenges of diagnosing and managing pre-fibrotic myelofibrosis: A case-based and practical approachAlexandros Rampotas, Rupen Hargreaves, Donal P McLornan
Current Research in Translational Medicine|February 26, 2022
Diagnostic and management strategies for Myeloproliferative Neoplasm-Unclassifiable (MPN-U): An international survey of contemporary practiceRupen Hargreaves, Claire N Harrison, Donal P McLornan
Cell Reports. Medicine|August 9, 2025
Inflammation reprogramming and immunomodulation: Next-generation treatments for atherosclerosisRobin P Choudhury, Rupen Hargreaves, Jason Chai, et al.
British Journal of Haematology|February 22, 2022
How I manage myeloproliferative neoplasm-unclassifiable: Practical approaches for 2022 and beyondDonal P McLornan, Rupen Hargreaves, Juan Carlos Hernández-Boluda, et al.
NPJ Cardiovascular Health|May 20, 2026
Clonal haematopoiesis and cardiovascular disease, defining risk, filling gaps, and framing the futureAlec P Morley, Paul Carter, Rupen Hargreaves, et al.
Cell Stem Cell|February 24, 2026
comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disordersYuqi Shen, Camelia Benlabiod, Edmund Watson, et al.
Pageof 1